JP2022554300A5 - - Google Patents

Info

Publication number
JP2022554300A5
JP2022554300A5 JP2022525387A JP2022525387A JP2022554300A5 JP 2022554300 A5 JP2022554300 A5 JP 2022554300A5 JP 2022525387 A JP2022525387 A JP 2022525387A JP 2022525387 A JP2022525387 A JP 2022525387A JP 2022554300 A5 JP2022554300 A5 JP 2022554300A5
Authority
JP
Japan
Prior art keywords
sequence
seq
vector system
otof
dual vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022525387A
Other languages
English (en)
Japanese (ja)
Other versions
JP7665609B2 (ja
JP2022554300A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/058265 external-priority patent/WO2021087296A1/en
Publication of JP2022554300A publication Critical patent/JP2022554300A/ja
Publication of JP2022554300A5 publication Critical patent/JP2022554300A5/ja
Priority to JP2025064211A priority Critical patent/JP2025106464A/ja
Application granted granted Critical
Publication of JP7665609B2 publication Critical patent/JP7665609B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022525387A 2019-10-30 2020-10-30 オトフェリン二重ベクター系及びそれを含む感音難聴を治療するための組成物 Active JP7665609B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025064211A JP2025106464A (ja) 2019-10-30 2025-04-09 オトフェリン二重ベクター系を使用して、感音難聴を治療するための組成物及び方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962928290P 2019-10-30 2019-10-30
US62/928,290 2019-10-30
US202062965776P 2020-01-24 2020-01-24
US62/965,776 2020-01-24
US202062971504P 2020-02-07 2020-02-07
US62/971,504 2020-02-07
US202063023058P 2020-05-11 2020-05-11
US63/023,058 2020-05-11
PCT/US2020/058265 WO2021087296A1 (en) 2019-10-30 2020-10-30 Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025064211A Division JP2025106464A (ja) 2019-10-30 2025-04-09 オトフェリン二重ベクター系を使用して、感音難聴を治療するための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2022554300A JP2022554300A (ja) 2022-12-28
JP2022554300A5 true JP2022554300A5 (OSRAM) 2023-11-02
JP7665609B2 JP7665609B2 (ja) 2025-04-21

Family

ID=75716489

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022525387A Active JP7665609B2 (ja) 2019-10-30 2020-10-30 オトフェリン二重ベクター系及びそれを含む感音難聴を治療するための組成物
JP2025064211A Pending JP2025106464A (ja) 2019-10-30 2025-04-09 オトフェリン二重ベクター系を使用して、感音難聴を治療するための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025064211A Pending JP2025106464A (ja) 2019-10-30 2025-04-09 オトフェリン二重ベクター系を使用して、感音難聴を治療するための組成物及び方法

Country Status (10)

Country Link
US (1) US12589168B2 (OSRAM)
EP (1) EP4051698A4 (OSRAM)
JP (2) JP7665609B2 (OSRAM)
KR (1) KR20220130093A (OSRAM)
BR (1) BR112022008214A2 (OSRAM)
CA (1) CA3159549A1 (OSRAM)
IL (1) IL292620A (OSRAM)
MX (1) MX2022005236A (OSRAM)
TW (1) TWI896570B (OSRAM)
WO (1) WO2021087296A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7240675B2 (ja) 2017-05-05 2023-03-16 ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. オトフェルリンを発現させるための組成物および方法
CN119410636A (zh) 2018-04-27 2025-02-11 分贝治疗公司 肌球蛋白15启动子及其用途
US11660353B2 (en) 2018-04-27 2023-05-30 Decibel Therapeutics, Inc. Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
BR112021013996A2 (pt) 2019-01-18 2021-10-26 Institut Pasteur Terapia gênica mediada por aav que recupera o gene otoferlina
EP3921032A4 (en) 2019-02-08 2022-11-30 Decibel Therapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
JP7562544B2 (ja) 2019-02-08 2024-10-07 デシベル セラピューティクス インコーポレイテッド ミオシン15プロモーター及びその使用
JP7665609B2 (ja) 2019-10-30 2025-04-21 デシベル セラピューティクス インコーポレイテッド オトフェリン二重ベクター系及びそれを含む感音難聴を治療するための組成物
CN116096905A (zh) 2020-02-21 2023-05-09 阿库斯股份有限公司 用于治疗人受试者的非年龄相关性听力损伤的组合物和方法
CA3174500A1 (en) 2020-04-01 2021-10-07 University Of Florida Research Foundation, Incorporated Dual aav-myo7a vectors with improved safety for the treatment of ush1b
KR20240053630A (ko) * 2021-09-10 2024-04-24 앵스띠뛰 파스퇴르 오토페를린의 이소형 5를 인코딩하는 이중 재조합 aav8 벡터 시스템 및 이의 용도
WO2023150689A2 (en) * 2022-02-04 2023-08-10 Decible Therapeutics, Inc. Gjb2 regulatory elements and uses thereof
EP4527933A4 (en) * 2022-05-17 2025-12-24 Eye & Ent Hospital Of Fudan Univ DUAL-SUPPORT SYSTEM FOR THE TREATMENT OF HEARING LOSS, AND ITS USE
IL322655A (en) * 2023-02-17 2025-10-01 Decibel Therapeutics Inc Method and compositions for administering a dual autopralin vector system
WO2025221253A1 (en) * 2024-04-17 2025-10-23 Decibel Therapeutics, Inc. Methods for treating sensorineural hearing loss using otoferlin dual vector systems

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720465D0 (en) 1997-09-25 1997-11-26 Oxford Biomedica Ltd Dual-virus vectors
US6436392B1 (en) 1998-05-20 2002-08-20 University Of Iowa Research Foundation Adeno-associated virus vectors
CA2386546A1 (en) 1999-10-07 2001-04-12 University Of Iowa Research Foundation Adeno-associated viruses and uses thereof
WO2001029243A1 (en) 1999-10-15 2001-04-26 Dalhousie University Method and vector for producing and transferring trans-spliced peptides
AU4445701A (en) 2000-03-24 2001-10-03 Centre National De La Recherche Scientifique-Cnrs Multiple human and mouse otoferlin isoforms
US20040072154A1 (en) 2000-12-22 2004-04-15 Morris David W. Novel compositions and methods for cancer
WO2002082904A2 (en) * 2001-04-13 2002-10-24 The Trustees Of The University Of Pennsylvania Method of treating or retarding the development of blindness
JP2003088388A (ja) 2001-09-14 2003-03-25 Herikkusu Kenkyusho:Kk 新規な全長cDNA
WO2005071092A1 (ja) 2004-01-22 2005-08-04 Dnavec Research Inc. サイトメガロウイルスエンハンサーおよびニワトリβ-アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖RNAウイルスベクターの製造方法
US20070161031A1 (en) 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements
WO2007127428A2 (en) 2006-04-28 2007-11-08 University Of Florida Research Foundation, Inc. Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery
JP5244103B2 (ja) 2006-08-09 2013-07-24 ホームステッド クリニカル コーポレイション 器官特異的蛋白質およびその使用方法
US7892824B2 (en) 2007-01-18 2011-02-22 University Of Missouri-Columbia Synthetic mini/micro-dystrophin genes to restore nNOS to the sarcolemma
FR2919305B1 (fr) 2007-07-26 2009-09-18 Genethon Ass Loi De 1901 Vecteurs viraux adeno-associes pour l'expression de la dysferline.
CN101990433B (zh) 2008-02-07 2014-11-05 马萨诸塞眼科耳科诊所 提高Atoh1表达的化合物
US20090215879A1 (en) * 2008-02-26 2009-08-27 University Of North Carolina At Chapel Hill Methods and compositions for adeno-associated virus (aav) with hi loop mutations
US8236557B2 (en) 2008-05-28 2012-08-07 University Of Missouri-Columbia Hybrid-AAV vectors to deliver large gene expression cassette
WO2010062905A2 (en) 2008-11-26 2010-06-03 The Regents Of The University Of California Lateral ventricle cell compositions and use for treating neural degenerative diseases
KR20200047642A (ko) 2010-04-23 2020-05-07 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 레베르 선천성 흑내장-1(lca1)의 치료를 위한 재조합 아데노-관련된 바이러스-구아닐레이트 사이클라제 조성물 및 방법
WO2013075008A1 (en) 2011-11-16 2013-05-23 University Of Florida Research Foundation Inc. Aav dual vector systems for gene therapy
KR102057540B1 (ko) * 2012-02-17 2019-12-19 더 칠드런스 호스피탈 오브 필라델피아 세포, 기관 및 조직으로의 유전자 전이를 위한 aav 벡터 조성물 및 방법
WO2013151663A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of membrane proteins
JP6342886B2 (ja) 2012-04-18 2018-06-13 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia Aavカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
US20150209406A1 (en) 2012-09-07 2015-07-30 Massachusetts Eye And Ear Infirmary Methods and compositions for regenerating hair cells and/or supporting cells
CA2904164C (en) 2013-03-11 2022-10-18 Fondazione Telethon Mir-204 and mir-211 and uses thereof
EP2986635B1 (en) 2013-04-18 2018-10-03 Fondazione Telethon Effective delivery of large genes by dual aav vectors
KR102298579B1 (ko) 2013-05-21 2021-09-07 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도
US11000597B2 (en) 2015-01-21 2021-05-11 University Of Florida Research Foundation, Incorporated Engineered receptor/ligand system for delivery of therapeutic agents
WO2016131981A1 (en) 2015-02-20 2016-08-25 Institut Pasteur Prevention and/or treatment of hearing loss or impairment
US20180327779A1 (en) 2015-03-03 2018-11-15 Fondazione Telethon (IT/IT) Multiple vector system and uses thereof
JP2018531926A (ja) 2015-09-17 2018-11-01 コーダ バイオセラピューティクス, インコーポレイテッド 神経学的障害を処置するための組成物および方法
CN116236591B (zh) * 2015-12-11 2026-02-27 马萨诸塞眼科耳科诊所 用于将核酸递送至耳蜗和前庭细胞的材料和方法
EP3393522B1 (en) 2015-12-22 2021-07-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Improved hybrid dual recombinant aav vector systems for gene therapy
WO2017216560A1 (en) 2016-06-15 2017-12-21 Oxford University Innovation Limited Dual overlapping adeno-associated viral vector system for expressing abc4a
EP3510161A4 (en) 2016-08-23 2020-04-22 Akouos, Inc. COMPOSITIONS AND METHODS FOR TREATING PERSONAL HEARING LOSS IN A PERSON
AU2018215785B2 (en) 2017-02-06 2023-08-31 Children's Medical Center Corporation Materials and methods for delivering nucleic acids to cochlear and vestibular cells
WO2018162748A1 (en) 2017-03-10 2018-09-13 Genethon Treatment of glycogen storage disease iii
JP7240675B2 (ja) * 2017-05-05 2023-03-16 ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. オトフェルリンを発現させるための組成物および方法
DE102018103924A1 (de) 2018-02-21 2019-08-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Gentherapeutische Behandlung von Schwerhörigkeit
IL276764B2 (en) * 2018-02-22 2026-05-01 Akouos Inc Compositions and methods for treating non-age-related hearing impairment in humans
US20190345516A1 (en) * 2018-03-12 2019-11-14 Musc Foundation For Research Development Methods for treating eye disease
AU2019237541B2 (en) 2018-03-23 2025-02-13 Editas Medicine, Inc. CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated Usher syndrome
CN119410636A (zh) * 2018-04-27 2025-02-11 分贝治疗公司 肌球蛋白15启动子及其用途
US11660353B2 (en) 2018-04-27 2023-05-30 Decibel Therapeutics, Inc. Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
WO2020093018A1 (en) * 2018-11-01 2020-05-07 University Of Florida Research Foundation, Incorporated A codon optimized otoferlin aav dual vector gene therapy
EP4063510A1 (en) 2018-11-07 2022-09-28 Akouos, Inc. Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
MX2021008542A (es) 2019-01-18 2021-11-12 Voyager Therapeutics Inc Métodos y sistemas para la producción de partículas de aav.
BR112021013996A2 (pt) 2019-01-18 2021-10-26 Institut Pasteur Terapia gênica mediada por aav que recupera o gene otoferlina
JP7562544B2 (ja) * 2019-02-08 2024-10-07 デシベル セラピューティクス インコーポレイテッド ミオシン15プロモーター及びその使用
EP3921032A4 (en) 2019-02-08 2022-11-30 Decibel Therapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
JP7665609B2 (ja) 2019-10-30 2025-04-21 デシベル セラピューティクス インコーポレイテッド オトフェリン二重ベクター系及びそれを含む感音難聴を治療するための組成物
CN116096905A (zh) 2020-02-21 2023-05-09 阿库斯股份有限公司 用于治疗人受试者的非年龄相关性听力损伤的组合物和方法
CA3174500A1 (en) 2020-04-01 2021-10-07 University Of Florida Research Foundation, Incorporated Dual aav-myo7a vectors with improved safety for the treatment of ush1b
WO2022178298A1 (en) 2021-02-19 2022-08-25 Decibel Therapeutics, Inc. Methods for treating sensorineural hearing loss using otoferlin dual vector systems
IL322655A (en) 2023-02-17 2025-10-01 Decibel Therapeutics Inc Method and compositions for administering a dual autopralin vector system

Similar Documents

Publication Publication Date Title
JP2022522996A5 (OSRAM)
JP2018537087A5 (OSRAM)
JP2023518596A5 (OSRAM)
FI3889173T3 (fi) Optimoitu tekijä viii:n geeni
JP2019506166A5 (OSRAM)
JP2023070682A5 (OSRAM)
JP2015521465A5 (OSRAM)
JP2023512824A5 (OSRAM)
JP2023532663A5 (OSRAM)
JP2020510428A5 (OSRAM)
RU2005136233A (ru) Выделенный рекомбинантный вирус гриппа и способы его получения
JP2023503637A5 (OSRAM)
FI3911354T3 (fi) Otoferliinigeenin palauttava AAV-välitteinen geeniterapia
NZ603348A (en) Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
JP2022513308A5 (OSRAM)
JP2014012022A5 (OSRAM)
PH12021552637A1 (en) Compositions useful for treatment of pompe disease
BR112022004027A2 (pt) Métodos para tratar doenças neovasculares oculares usando variantes de aav2 que codificam aflibercepte
JP2024507837A5 (OSRAM)
JP2009515529A5 (OSRAM)
PE20221254A1 (es) Proteina vp1 modificada aislada de la capside del virus adeno-asociado de serotipo 5 (aav5), capside y vector basado en la misma
BR112023019056A2 (pt) Métodos para tratar doenças oculares usando variantes de aav2 que codificam aflibercepte
JP2018537089A5 (OSRAM)
PE20240915A1 (es) Composiciones y metodos para tratar la enfermedad de fabry
JP2017529868A5 (OSRAM)